Volume 24, Number 121 (2-2015)                   J Mazandaran Univ Med Sci 2015, 24(121): 431-445 | Back to browse issues page


XML Persian Abstract Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Akhtari J, Abastabar M, Abediankenari S. Application of Nanocarriers in Immunogenicity against Diseases. J Mazandaran Univ Med Sci. 2015; 24 (121) :431-445
URL: http://jmums.mazums.ac.ir/article-1-5298-en.html

Abstract:   (2796 Views)
The relationship between nanotechnology and immunology can be evaluated from different aspects. The application of nanotechnology and immunology is widespread and has important features in medical biotechnology. Delivery of active immunological compounds to the target sites using nano-carriers is one of the issues related to nanotechnology and immunology. Moreover, successful application of nanotechnology in the field of immunology resulted in development of new generations of vaccines, adjuvants and immunomodulatory drugs that aim to improve response to infectious and non-infectious diseases. Nanotechnology plays a key role in the formation of new vaccines and immunosuppressive agents. On the other hand, the manipulation and control of objects at the nano scale level can promote our conception of immune responses. In current review we discuss the effect of size, charge, shape, hydrophobic and porosity properties of a compound on the immune response and investigate the role of nanotech‌nology in engineering of each of these features. It is expected that in future the collaboration between nanotech‌nology and immunology could lead to new strategies in prevention and treatment of human diseases.
Full-Text [PDF 272 kb]   (838 Downloads)    
Type of Study: Review | Subject: Immunology

Add your comments about this article : Your username or email:
Write the security code in the box

Send email to the article author


© 2015 All Rights Reserved | Journal of Mazandaran University of Medical Sciences

Designed & Developed by : Yektaweb